用氨基酸修饰的G-四重奏水凝,用于在体内释放 响应葡萄糖的胰岛素
Dharmesh Jinagal1, Natasha2, Debashish Paul2
1Department of Chemistry, IIT Bhilai, Durg 491002, India. suchetanp@iitbhilai.ac.in.
概括
一种新的水凝释放胰岛素作为对葡萄糖的反应,有效地控制了糖尿病老鼠的血糖水平. 这种生物材料对先进的糖尿病护理有前途.
科学领域:
- 生物材料科学 生物材料科学
- 药物输送系统 药物输送系统
- 内分泌学 在内分泌学.
背景情况:
- 糖尿病需要持续的血糖监测和胰岛素的管理.
- 目前的糖尿病管理策略在精确的胰岛素输送和血糖控制方面面临挑战.
- 开发智能,响应性材料对于改善治疗结果至关重要.
研究的目的:
- 开发一种在位形成凝系统,用于输送葡萄糖敏感胰岛素.
- 为了研究水凝的特性,包括其成分和胰岛素释放特征.
- 在1型糖尿病大鼠模型中评估水凝在体内疗效.
主要方法:
- 一种含有G四重奏,氨基酸和甲基酸的凝的合成.
- 描述水凝在位形成和结构性质的特征.
- 评估葡萄糖刺激的胰岛素释放在体外.
- 在活体研究中,研究了一种链佐素诱导的1型糖尿病大鼠模型,以监测血糖水平.
主要成果:
- 水凝成功地在现场形成,并证明了模块化的葡萄糖反应性胰岛素释放.
- 该配方表现出无毒的特性.
- 在1型糖尿病大鼠模型中,持续的euglycemic水平得到维持.
- 该系统在管理高血糖症方面被证明是有效的.
结论:
- 开发的水凝是一种安全有效的平台,用于提供对葡萄糖敏感的胰岛素.
- 这种创新方法为改善糖尿病管理提供了一个有希望的策略.
- 进一步的研究可能会导致智能胰岛素输送系统的临床应用.
相关概念视频
Glucagon-like Receptor Agonists
828
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
828
Hormones Regulating Blood Glucose
6.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
6.4K
Insulin Formulations: Types and Delivery
632
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
632
Insulin: Biosynthesis, Chemistry, and Preparation
1.2K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
2.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
2.1K
Insulin Secretory Vesicles
6.4K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.4K


